Crossmark

In-home assessment of either topical fluralaner or topical selamectin for flea control in naturally infested cats in West Central Florida, USA

Crossref DOI link: https://doi.org/10.1186/s13071-018-2995-1

Published Online: 2018-07-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dryden, Michael W.

Canfield, Michael S.

Bocon, Cara

Phan, Letitia

Niedfeldt, Emily

Kinnon, Amanda

Warcholek, Stanislaw A.

Smith, Vicki

Bress, Todd S.

Smith, Nicole

Heaney, Kathleen

Royal, Christine

Normile, Dorothy

Armstrong, Robert http://orcid.org/0000-0003-2974-4161
Sun, Fangshi
License Information

Text and Data Mining valid from 2018-07-16
More Information

Article History

Received: 1 March 2018

Accepted: 5 July 2018

First Online: 16 July 2018

Ethics approval

: The present research was approved and complied with the regulations set forth by the Kansas State University Institutional Animal Care and Use Committee. This research protocol IACUC # 3926 approved 09 May 2017. Each pet owner was required to read and sign an informed consent form prior to enrolling their dogs into this field trial.

: Not applicable.

: MWD has had research projects funded at Kansas State University and lectures sponsored by Merck Animal Health, Madison, NJ, USA and Zoetis manufacturers of Bravecto®, Revolution®, and Simparica® that were evaluated in these investigations. MC has had lectures sponsored by Merck Animal Health, Madison, NJ, USA and Zoetis, manufacturers of Bravecto®, Revolution®, and Simparica® that were evaluated in these investigations. KH, DN, CR, RA and FS are currently employed by Merck Animal Health, Madison, NJ, USA.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.